glp-1 heart muscle Mechanisms of Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit GLP-1 Drugs & What They

Availability of data and materials Data sharing is not applicable to this article as no datasets were generated or analyzed during the current work

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

This compound remains the subject of intensive research into the regulation of energy metabolism, glucose metabolism and the mechanisms involved in the bodys energy balance

Originally for diabetes and weight loss, new studies have shown they could protect brain cells and preserve memory

It is important to develop a single pharmacological medication with multiple functions, such as tirzepatide

Think of it this way